Health Catalyst exceeded its quarterly guidance on both total revenue and Adjusted EBITDA in Q1 2025. The company reported total revenue of $79.4 million, a 6% increase year-over-year, and Adjusted EBITDA of $6.3 million, an 86% increase year-over-year. Net loss increased by 15% to $23.7 million.
Total revenue for Q1 2025 was $79.4 million, a 6% increase compared to Q1 2024.
Adjusted EBITDA for Q1 2025 was $6.3 million, an 86% increase compared to Q1 2024.
Net loss for Q1 2025 was $23.7 million, a 15% increase compared to Q1 2024.
Added 10 net new Platform Clients in Q1 2025.
For the second quarter of 2025, Health Catalyst expects total revenue of approximately $80.5 million and Adjusted EBITDA of approximately $8 million. For the full year 2025, the company expects total revenue of approximately $335 million, technology revenue of approximately $220 million, and Adjusted EBITDA of approximately $41 million.
Visualization of income flow from segment revenue to net income